MyAverix Finance
HK · Healthcare
Innovent Biologics Inc (1801)
Biotechnology
Innovent Biologics Inc (1801) is listed on HK in the Healthcare sector. Industry: Biotechnology. As of 2026-05-21, reported market cap is $142.33B, P/E ratio is 151.94, net margin is 6.2%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 1801
Innovent Biologics Inc (1801) — FAQ
What is Innovent Biologics Inc's market cap?
Innovent Biologics Inc (1801) has a reported market cap of $142.33B (data as of 2026-05-21).
What is 1801's P/E ratio?
The price-to-earnings (P/E) ratio for Innovent Biologics Inc (1801) is 151.94 (data as of 2026-05-21).
Does Innovent Biologics Inc pay a dividend?
Dividend yield is not available in the current snapshot for Innovent Biologics Inc (1801). Check the MyAverix Finance app for the latest dividend data.
What sector is Innovent Biologics Inc in?
Innovent Biologics Inc (1801) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 1801 listed on?
1801 is listed on HK.
What is Innovent Biologics Inc's net margin?
Innovent Biologics Inc (1801) reports a net margin of 6.2% (data as of 2026-05-21).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.